Education
About Us
Working with TipRanks
Follow Us
Gaslightwala Abizer Insider Profile
4 Followers
Gaslightwala Abizer, CEO, Director at Akari Therapeutics, holds 298.57K shares in Akari Therapeutics (Ticker: AKTX). Most recently, Gaslightwala Abizer Bought 21,000 shares of Akari Therapeutics on Aug 29, 2025 for an estimated value of $19.54K.
Gaslightwala Abizer Akari Therapeutics (AKTX)CEO, Director
Akari Therapeutics (AKTX)
CEO, Director
Ranked #78,286 out of 103,431 Corporate Insiders
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-19.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Gaslightwala Abizer's holdings
Insider Roles
CEO, Director
Roles that Gaslightwala Abizer holds in companies
Most Profitable Insider Trade
The most profitable trade made by Gaslightwala Abizer
Gaslightwala Abizer's Trading History
List of latest transactions for each holding click on a transaction to see Gaslightwala Abizer's performance on stock
You May Also Like
Gaslightwala Abizer insider profile FAQ
What is the percentage of profitable transactions made by Gaslightwala Abizer?
The percentage of profitable transactions made by Gaslightwala Abizer is 25%.
What is the average return per transaction made by Gaslightwala Abizer?
The average return per transaction made by Gaslightwala Abizer is -19.50%.
What stocks does Gaslightwala Abizer hold?
Gaslightwala Abizer holds: AKTX stocks.
What was Gaslightwala Abizer’s latest transaction?
Gaslightwala Abizer latest transaction was an Informative Buy of $19.54K.
What was Gaslightwala Abizer's most profitable transaction?
Gaslightwala Abizer’s most profitable transaction was an Informative Buy of AKTX stock on August 29, 2025. The return on the trade was 7.60%.
What is Gaslightwala Abizer's role in Akari Therapeutics?
Gaslightwala Abizer's role in Akari Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.